DXVX 둜고

DXVX (180400) μ£Όκ°€ 및 μ’…λͺ© 정보

DXVX μ‹€μ‹œκ°„ μ£Όκ°€

DXVX ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 1,775 원
λ³€λ™λŸ‰ β–Ό 63.00 원
변동λ₯  -3.43%
κ±°λž˜λŸ‰ 128,329
κ±°λž˜λŒ€κΈˆ 228,181,796 원

DXVX 일별 μ£Όκ°€

DXVX의 κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
11/30/2025 1,798 1,879 1,788 1,863 134,383 245,644,365
12/1/2025 1,818 1,865 1,790 1,864 116,500 211,047,914
12/2/2025 1,865 1,870 1,781 1,788 162,979 293,888,317
12/3/2025 1,788 1,804 1,705 1,750 177,831 308,495,095
12/4/2025 1,750 1,800 1,685 1,777 254,150 448,693,082
12/7/2025 1,777 1,777 1,717 1,733 95,582 165,932,705
12/8/2025 1,716 1,798 1,716 1,750 84,835 149,541,909
12/9/2025 1,745 1,810 1,716 1,808 112,381 198,437,362
12/10/2025 1,820 1,887 1,810 1,838 138,975 256,786,766
12/11/2025 1,838 1,840 1,730 1,775 128,329 228,181,796

κ΄€λ ¨ ν…Œλ§ˆ

  • 문재인 : μˆ˜μ • ν™•λ₯ μ΄ 높은 μˆ˜μ •λž€μ„ μ„ λ³„ν•΄μ£ΌλŠ” μ„œλΉ„μŠ€λ₯Ό μ œκ³΅ν•˜λŠ” νšŒμ‚¬λ‘œ, μΆœμ‚°μ§€μ›μ •μ±…μ˜ 수혜 κΈ°λŒ€κ°μœΌλ‘œ μ£Όλͺ©λ°›μ€ λ°” 있음
  • μ§€μΉ΄λ°”μ΄λŸ¬μŠ€ : λ³΄κ±΄λ³΅μ§€λΆ€λ‘œλΆ€ν„° 감염병 μœ„κΈ° λŒ€μ‘κΈ°μˆ  κ°œλ°œμ‚¬μ—… κ³Όμ œμ— μ„ μ •λ˜μ—ˆμœΌλ©° κ³ μœ„ν—˜μ„± 감염체인 μ§€μΉ΄, λ©”λ₯΄μŠ€ λ°”μ΄λŸ¬μŠ€λ₯Ό 진단할 수 μžˆλŠ” λΆ„μžμ§„λ‹¨κΈ°κΈ° 2개 ν’ˆλͺ©μ„ μˆ˜μΆœν•œ λ°” 있음

DXVX νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 873μ–΅ 905μœ„ 49,219,432 10.06% ν—¬μŠ€μΌ€μ–΄ 의료μž₯λΉ„/μš©ν’ˆ 2,890 1,309

DXVX κΈ°μ—… κ°œμš”

DXVXλŠ” 2001λ…„ 6μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ μœ μ „μ²΄ 및 체외진단 μ„œλΉ„μŠ€ λ“±μ˜ μ˜λ£Œμ§„λ‹¨ 사업과 λ°”μ΄μ˜€ν—¬μŠ€μΌ€μ–΄ 사업을 μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ μ˜λ£Œμ§„λ‹¨μ‚¬μ—…μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. μ‹ κ·œ ν—¬μŠ€μΌ€μ–΄ 사업은 ν•΄μ™Έμ‹œμž₯ 특히, μ€‘κ΅­μ‹œμž₯을 μ€‘μ‹¬μœΌλ‘œ 맘&베이비 λŒ€μƒμ˜ λ§ˆμ΄ν¬λ‘œλ°”μ΄μ˜΄ κ΄€λ ¨ μ œν’ˆμ„ ν¬ν•¨ν•œ λ‹€μ–‘ν•œ ν—¬μŠ€μΌ€μ–΄ λΈŒλžœλ“œ μ œν’ˆμ„ 개발 및 수좜 μ§„ν–‰ 쀑에 있으며, ν–₯ν›„ μœ μ „μ²΄ 뢄석 및 체외진단 μ‚¬μ—…λΆ€λ¬ΈμœΌλ‘œ ν™•λŒ€ μΆ”μ§„ν•  κ³„νšμ΄λ‹€.

DXVX AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” DXVX을 κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

DXVX μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ DXVX을 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ λ§€λ§€ μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  DXVX κ΄€λ ¨ λ‰΄μŠ€

DXVXλŠ” νšŒμ‚¬κ°€ μ΅œλŒ€μ£Όμ£Όλ‘œ μžˆλŠ” μ˜₯μŠ€ν¬λ“œλ°±λ©”λ”•μŠ€(OVM)κ°€ 졜근 μ£Όλ ₯ ν•­μ•”λ°±μ‹  'OVM-200'의 1상 μž„μƒμ‹œν—˜μ—μ„œ Last Patient Out(LPO) λ§ˆμΌμŠ€ν†€μ„ λ‹¬μ„±ν–ˆλ‹€κ³  20일 λ°ν˜”λ‹€. LPOλŠ” μž„μƒμ—°κ΅¬μ— μ°Έμ—¬ν•œ ν™˜μžλ“€μ˜ νˆ¬μ•½μ΄ λλ‚œ μž„μƒμ’…λ£Œ μ‹œμ μ„ μ˜λ―Έν•˜λ©°, 이후 μ•ˆμ „μ„±κ³Ό νš¨κ³Όμ— λŒ€ν•œ μ΅œμ’… 평가가 μ§„ν–‰λœλ‹€. OVM-200 μž„μƒμ‹œν—˜μ˜ 두 번째 뢀뢄인 Phase 1bλŠ” μ˜κ΅­λ‚΄ 4개 μ£Όμš” λ³‘μ›μ—μ„œ μ΅œλŒ€ 6κ°œμ›” λ™μ•ˆ OVM-200 치료λ₯Ό 받은 ν™˜μžλ“€μ„ λŒ€μƒμœΌλ‘œ 진행됐닀. OVM-200은 OVM의 μž¬μ‘°ν•© μ˜€λ²„λž˜ν•‘ νŽ©νƒ€μ΄λ“œ(ROP) ν”Œλž«νΌμ„ μ΄μš©ν•΄ 개발된 μƒˆλ‘œμš΄ ν˜•νƒœμ˜ λ©΄μ—­μΉ˜λ£Œμ œλ‹€. 암세포가 λ©΄μ—­ 곡격을 ν”Όν•˜λ„λ‘ λ•λŠ” λ‹¨λ°±μ§ˆμΈ 'Survivin'을 ν‘œμ ν•˜λ©°, 이번 μž„μƒμ€ μ‚¬λžŒμ—κ²Œ 처음 νˆ¬μ—¬λœ μ‚¬λ‘€λœ 사둀닀. 이번 μž„μƒμ€ 초기 μ•ˆμ „μ„± ν”„λ‘œνŒŒμΌμ„ ν™•λ¦½ν•˜κ³ , λΉ„μ†Œμ„Έν¬νμ•”(NSCLC), 전립선암, λ‚œμ†Œμ•” λ“± μ„Έ κ°€μ§€ μ’…μ–‘ μœ ν˜•μ˜ ν™˜μžλ“€μ—μ„œ λ©΄μ—­λ°˜μ‘μ„ ν‰κ°€ν•˜λŠ” 것에 μ΄ˆμ μ„ λ§žμ·„λ‹€. 총 36...

λ””μ—‘μŠ€μ•€λΈŒμ΄μ—‘μŠ€(DXVX)λŠ” κ²½μ˜μ΄κ΄„ 및 사업뢀문 μœ κ±΄μƒ 사μž₯을 각자 λŒ€ν‘œμ΄μ‚¬μ— μ„ μž„ν•œλ‹€κ³  5일 λ°ν˜”λ‹€. 이λ₯Ό 톡해 νšŒμ‚¬μ˜ ...

DXVXλŠ” κ²½μ˜μ΄κ΄„ 및 사업뢀문 μœ κ±΄μƒ 사μž₯을 각자 λŒ€ν‘œμ΄μ‚¬μ— μ„ μž„ν•΄ νšŒμ‚¬μ˜ 미래 μ‚¬μ—…κ³„νš μ—­λŸ‰μ„ λ°°κ°€ν•˜κ³ , 코리(Coree)μ™€μ˜ μ‹œλ„ˆμ§€ 효과λ₯Ό κ·ΉλŒ€ν™”ν•œλ‹€κ³  5일 λ°ν˜”λ‹€. μœ κ±΄μƒ λŒ€ν‘œμ΄μ‚¬λŠ” μ‚¬μ—…κ°œλ°œ μ „λ¬Έκ°€λ‘œ λ‹€μ–‘ν•œ κ²½ν—˜κ³Ό μ—­λŸ‰μ„ λ³΄μœ ν•œ 인물둜 κΌ½νžŒλ‹€. DXVXλŠ” 유 λŒ€ν‘œ μ„ μž„μ„ 톡해 λ³€ν™”ν•˜λŠ” λŒ€λ‚΄μ™Έ ν™˜κ²½μ— 적극적으둜 λŒ€μ‘ν•΄ λ‚˜κ°ˆ κ³„νšμ΄λ‹€. 유 λŒ€ν‘œμ΄μ‚¬λŠ” 2005λ…„ λΆκ²½ν•œλ―ΈITλ₯Ό μ‹œμž‘μœΌλ‘œ λΆκ²½ν•œλ―Έλ§ˆμΌ€νŒ…κ·Έλ£Ή(HMG), μ˜€λΈŒλ§˜μ½”λ¦¬μ•„, 코리포항 및 ν•œκ΅­λ°”μ΄μ˜€νŒœ λ“± 코리 μ£Όμš” 계열사 및 DXVX μžνšŒμ‚¬μ˜ λŒ€ν‘œμ΄μ‚¬λ₯Ό μ—­μž„ν•΄ μ™”λ‹€. 특히 μž„μ’…μœ€ λΆκ²½ν•œλ―Έμ•½ν’ˆ 동사μž₯의 졜츑근으둜 ν™œλ™ν•˜λ©° μœ μˆ˜ν•œ μ„±κ³Όλ₯Ό λ„μΆœν•΄ 온 κ²ƒμœΌλ‘œ μ•Œλ €μ‘Œλ‹€. μœ κ±΄μƒ DXVX λŒ€ν‘œμ΄μ‚¬λŠ” "λŒ€λ‚΄μ™Έμ μœΌλ‘œ μ–΄λ €μš΄ κ²½μ˜ν™˜κ²½ μ†μ—μ„œ λŒ€ν‘œμ΄μ‚¬λΌλŠ” 쀑책을 맑게 λ˜μ–΄ κΉŠμ€ 사λͺ…감과 ν•¨κ»˜ 무거운 μ±…μž„κ°μ„ λŠλ‚€λ‹€"라며 "μƒˆλ‘œμš΄ 도약을 μœ„ν•΄ νšŒμ‚¬μ˜ μ—­λŸ‰μ„ ν•˜λ‚˜λ‘œ λͺ¨μœΌλŠ” ν•œνŽΈ, 투λͺ…ν•˜κ³  μ±…μž„ μžˆλŠ” κ²½μ˜μ„ 톡해 μ‹ λ’°λ₯Ό νšŒλ³΅ν•˜κ³ , 쑰직의 μ²΄μ§ˆμ„ κ·Όλ³ΈλΆ€...

DXVX 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 33,946,577,478 -27.38% -21,596,592,945 -78.72% -51,483,903,348 -84.95%
2023.4Q 46,745,087,441 45.24% -12,084,041,763 -558.72% -27,836,035,041 -2770.27%
2022.4Q 32,184,380,000 330.86% 2,634,286,300 155.04% -969,805,400 87.70%
2021.4Q 7,469,835,000 -2.94% -4,785,959,000 19.95% -7,884,203,500 -9.83%

μˆœλ§€μˆ˜λŸ‰

개인: -12,586

κΈ°κ΄€: 0

외인: 12,586

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: -155,850

κΈ°κ΄€: -98,881

외인: 357,715

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-12-12 -12,586 - 12,586
2025-12-11 -48,348 - 48,353
2025-12-10 -21,938 - 21,938
2025-12-09 -28,052 - 28,052
2025-12-08 -4,141 - 4,141
2025-12-05 -23,427 - 23,426
2025-12-04 -11,215 - 10,357
2025-12-03 22,217 - -22,217
2025-12-02 12,266 - -12,266
2025-12-01 4,826 - -4,826
2025-11-28 -40,193 - 40,193
2025-11-27 -60,519 - 61,353
2025-11-26 -17,470 - 17,448
2025-11-25 26,850 - -29,004
2025-11-24 20,866 - -22,066
2025-11-21 -5,863 - 5,863
2025-11-20 -6,051 - 6,051
2025-11-19 29,658 - -31,361
2025-11-18 -7,204 - 6,207
2025-11-17 43,932 - -43,932
2025-11-14 857 - -857

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-12-12 -125,535 - 119,439
2025-12-11 -112,949 - 106,853
2025-12-10 -64,601 - 58,500
2025-12-09 -42,663 - 36,562
2025-12-08 -14,611 - 8,510
2025-12-05 -10,470 - 4,369
2025-12-04 12,957 - -19,057
2025-12-03 24,172 - -29,414
2025-12-02 1,955 - -7,197
2025-12-01 -10,311 - 5,069
2025-11-28 -15,137 - 9,895
2025-11-27 25,056 - -30,298
2025-11-26 85,575 - -91,651
2025-11-25 103,045 - -109,099
2025-11-24 76,195 - -80,095
2025-11-21 55,329 - -58,029
2025-11-20 61,192 - -63,892
2025-11-19 67,243 - -69,943
2025-11-18 37,585 - -38,582
2025-11-17 44,789 - -44,789
2025-11-14 857 - -857

DXVX μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
54,789,920,988 105.82% -5.82%

DXVX 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
λ‚΄μˆ˜ [ν—¬μŠ€μΌ€μ–΄] 75.22%
수좜 [ν—¬μŠ€μΌ€μ–΄] 9.68%
λ‚΄μˆ˜ [μ˜λ£Œμ§„λ‹¨] 7.95%
수좜 [μ˜λ£Œμ§„λ‹¨] 7.05%
λ‚΄μˆ˜ [μ‹ μ•½] 0.1%

DXVX 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 2,484 (1.94%)

졜근 곡맀도 μž”κ³ : 98,881 (0.2%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2025-12-12 1,775 2,484 1.94%
2025-12-11 1,838 714 0.51%
2025-12-10 1,808 1,311 1.17%
2025-12-09 1,750 1,424 1.68%
2025-12-08 1,733 1,746 1.83%
2025-12-05 1,777 5,140 2.02%
2025-12-04 1,750 1,624 0.91%
2025-12-03 1,788 8,471 5.20%
2025-12-02 1,864 809 0.69%
2025-12-01 1,863 1,621 1.21%
2025-11-28 1,797 0 0.00%
2025-11-27 1,775 116 0.09%
2025-11-26 1,770 3,522 2.29%
2025-11-25 1,770 12,413 6.08%
2025-11-24 1,883 4,738 1.29%
2025-11-21 1,955 1,686 0.86%
2025-11-20 1,838 3,640 1.10%
2025-11-19 1,843 10,226 5.32%
2025-11-18 1,945 4,177 2.84%
2025-11-17 2,025 10,938 4.27%
2025-11-14 2,220 943 0.70%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2025-12-10 1,808 98,881 0.20%
2025-12-09 1,750 98,881 0.20%
2025-12-08 1,733 161,857 0.33%
2025-12-05 1,777 166,003 0.34%
2025-12-04 1,750 175,006 0.36%
2025-12-03 1,788 175,112 0.36%
2025-12-02 1,864 174,822 0.36%
2025-12-01 1,863 174,961 0.36%
2025-11-28 1,797 174,739 0.36%
2025-11-27 1,775 235,417 0.48%
2025-11-26 1,770 261,801 0.53%
2025-11-25 1,770 260,443 0.53%
2025-11-24 1,883 248,885 0.51%
2025-11-21 1,955 253,196 0.51%
2025-11-20 1,838 187,837 0.38%
2025-11-19 1,843 275,179 0.56%
2025-11-18 1,945 266,742 0.54%
2025-11-17 2,025 269,956 0.55%
2025-11-14 2,220 273,823 0.56%
2025-11-13 2,220 281,834 0.57%
2025-11-12 2,060 289,056 0.59%

DXVX μ—…μ’… λ‚΄ 비ꡐ

의료μž₯λΉ„/μš©ν’ˆ μ—…μ’…(100개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© DXVX μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 904.653 3,289.04 60μœ„
PER(졜근4λΆ„κΈ°) -1.776 -103.4 52μœ„
PBR -16.517 6.26 99μœ„
ROE(졜근4λΆ„κΈ°) -267.665 -33.55 93μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) -63.619 -108.74 79μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -151.662 -143.95 84μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 342.442 115.01 5μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 339.466 737.56 50μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) -215.966 -11.41 90μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -514.839 -48.78 92μœ„